Selective growth inhibitory effect of biochanin a against intestinal tract colonizing bacteria

Molecules

Volumn 15, Issue 3, 2010, Pages 1270-1279

  Sklenickova, Olga ^a   Flesar, Jaroslav ^a   Kokoska, Ladislav ^a   Vlkova, Eva ^a   Halamova, Katerina ^a   Malik, Jan ^a  

^a CZECH UNIVERSITY OF LIFE SCIENCES PRAGUE   (Czech Republic)

Author keywords

Bifidobacteria; Clostridia; Isoflavonoid; Phytoestrogen; Selective antimicrobial activity

Indexed keywords

ANTIINFECTIVE AGENT; BIOCHANIN A; GENISTEIN;

ANIMAL; ARTICLE; BIFIDOBACTERIUM; CLASSIFICATION; CLOSTRIDIUM; DRUG EFFECT; GROWTH, DEVELOPMENT AND AGING; HUMAN; INTESTINE; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; SPECIES DIFFERENCE;

ANIMALS; ANTI-BACTERIAL AGENTS; BIFIDOBACTERIUM; CLOSTRIDIUM; GENISTEIN; HUMANS; INTESTINES; MICROBIAL SENSITIVITY TESTS; SPECIES SPECIFICITY;

EID: 77950364491     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules15031270     Document Type: Article

References (57)

1. Viswanathan, V. K.; Hodges, K.; Hecht, G. Enteric infection meets intestinal function: how bacterial pathogens cause diarrhea. Nat. Rev. Microbiol. 2009, 7, 1-10.
2. Sullivan, A.; Nord, C. E. The place of probiotics in human intestinal infections. Int. J. Antimicrob. Agents 2002, 20, 313-319. (Pubitemid 35300426)
3. Kuijper, E. J.; Coignard, B.; Tull, P. Emergence of Clostridium difficile-associated disease in North America and Europe. Clin. Microbiol. Infect. 2006, 12, 2-18. (Pubitemid 44362038)
4. Fooks, L. J.; Fuller, R.; Gibson, G. R. Prebiotics, probiotics and human gut microbiology. Int. Dairy J. 1999, 9, 53-61. (Pubitemid 29342045)
5. Bartlett, J. G. Narrative review: The new epidemic of clostridium difficile-associated enteric disease. Ann. Intern Med. 2006, 145, 758-764.
6. Larson, H. E.; Price, A. B.; Honour, P.; Borriello, S. P. Clostridium difficile and the aetiology of pseudomembranous colitis. Lancet 1978, 311, 1063-1066
7. Lavigne, J.-P.; Bouziges, N.; Sotto, A.; Leroux, J.-L.; Michaux-Charachon, S. Spondylodiscitis Due to Clostridium ramosum Infection in an Immunocompetent Elderly Patient. J. Clin. Microbiol. 2003, 41, 2223-2226. (Pubitemid 36576571)
8. Turkoglu, O. F.; Solaroglu, I.; Tun, K.; Beskonakli, E.; Taskin, Y. Secondary infection of intracranial hydatid cyst with Clostridium ramosum. Child's Nerv. Syst. 2005, 21, 1004-1007. (Pubitemid 41631104)
9. Borregagarcia, P.; Jimenezmejias, M. E.; Chinchon, I.; Cuellocontreras, J. A. Paravertebral abscess and meningitis by Clostridium clostridioforme. Med. Clin. -Barcelona 1994, 102, 279-279.
10. Spitzer, R. D.; Ratzan, K. R. Chronic osteomyelitis due to Clostridium clostridiiforme. South. Med. J. 1991, 84, 671-672.
11. Marrie, T. J.; Costerton, J. W. Mode of growth of bacterial pathogens in chronic polymicrobial human osteomyelitis. J. Clin. Microbiol. 1985, 22, 924-933.
12. Drudy, D.; Harnedy, N.; Fanning, S.; Hannan, M.; Kyne, L. Emergence and control of fluoroquinolone-resistant, toxin a-negative, toxin B-Positive Clostridium difficile. Infect. Control Hosp. Epidemiol. 2007, 28, 932-940. (Pubitemid 47218272)
13. Hookman, P.; Barkin, J. S. Clostridium difficile associated infection, diarrhea and colitis. World J. Gastroentero. 2009, 15, 1554-1580.
14. Bartlett, J. G. The case for vancomycin as the preferred drug for treatment of Clostridium difficile infection. Clin. Infect. Dis. 2008, 46, 1489-1492.
15. O'Horo, J.; Safdar, N. The role of immunoglobulin for the treatment of Clostridium difficile infection: a systematic review. Int. J. Infect Dis. 2009, 13, 663-667.
16. Huang, H. H.; Weintraub, A.; Fang, H.; Nord, C. E. Antimicrobial resistance in Clostridium difficile. Int. J. Antimicrob. Agents 2009, 34, 516-522.
17. Sasaki, Y.; Yamamoto, K.; Tamura, Y.; Takahashi, T. Tetracycline- resistance genes of Clostridium perfringens, Clostridium septicum and Clostridium sordellii isolated from cattle affected with malignant edema. Vet. Microbiol. 2001, 83, 61-69. (Pubitemid 32778461)
18. Fekety, R.; Shah, A. B. Diagnosis and treatment of Clostridium difficile colitis. JAMA 1993, 269, 71-75. (Pubitemid 23006526)
19. Fekety, R.; Silva, J.; Kauffman, C.; Buggy, B.; Deery, H. G. Treatment of antibiotic-associated clostridium difficile colitis with oral vancomycin - comparasion of 2 dosage regimens. Am. J. Med. 1989, 86, 15-19.
20. Walters, B. A. J.; Roberts, R.; Stafford, R.; Seneviratne, E. Relapse on antibiotic associated colitisendogenous persistence of Clostridium-difficile during vancomycin therapy. Gut 1983, 24, 206-212.
21. Neu, H. C. The crisis in antibiotic-resistance. Science 1992, 257, 1064-1073.
22. McFarland, L. V. A randomized placebo-controlled trial of Saccharomyces-boulardii in combination with standard antibodies for Clostridium difficile disease. JAMA 1994, 272, 518-518.
23. Tannock, G. W. Identification of Lactobacilli and Bifidobacteria. Curr. Issues Mol. Biol. 1999, 1, 53-64.
24. Fuller, R. Probiotics in human medicine. Gut 1991, 32, 439-442.
25. Trejo, F. M.; Minnaard, J.; Perez, P. F.; De Antoni, G. L. Inhibition of Clostridium difficile growth and adhesion to enterocytes by Bifidobacterium supernatants. Anaerobe 2006, 12, 186-193. (Pubitemid 44331635)
26. Lee, Y. J.; Yu, W. K.; Heo, T. R. Identification and screening for antimicrobial activity against Clostridium difficile of Bifidobacterium and Lactobacillus species isolated from healthy infant faeces. Int. J. Antimicrob. Agents 2003, 21, 340-346.
27. Cowan, M. M. Plant products as antimicrobial agents. Clin. Microbiol. Rev. 1999, 12, 564-582.
28. Rios, J. L.; Recio, M. C. Medicinal plants and antimicrobial activity. J. Ethnopharmacol. 2005, 100, 80-84.
29. Cushnie, T. P. T.; Lamb, A. J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343-356.
30. Dakora, F. D.; Phillips, D. A. Diverse functions of isoflavonoids in legumes transcend antimicrobial definitions of phytoalexins. Physiol. Mol. Plant Pathol. 1996, 49, 1-20.
31. Johnson, G.; Maag, D. D.; Johnson, D. K.; Thomas, R. D. Possible role of phytoalexins in resistance of sugarbeet (Beta vulgaris) to Cercospora beticola. Physiol. Plant Pathol. 1976, 8, 225-230.
32. Dastidar, S. G.; Manna, A.; Kumar, K. A.; Mazumdar, K.; Dutta, N. K.; Chakrabarty, A. N.; Motohashi, N.; Shirataki, Y. Studies on the antibacterial potentiality of isoflavones. Int. J. Antimicrob. Agents 2004, 23, 99-102. (Pubitemid 38083319)
33. Gnanamanickam, S. S.; Smith, D. A. Selective toxicity of isoflavonoid phytoalexins to Gram-positive bacteria. Phytopathology 1980, 70, 894-896.
34. Hong, H. K.; Landauer, M. R.; Foriska, M. A.; Ledney, G. D. Antibacterial activity of the soy isoflavone genistein. J. Basic Microbiol. 2006, 46, 329-335.
35. Verdrengh, M.; Collins, L. V.; Bergin, P.; Tarkowski, A. Phytoestrogen genistein as an anti-staphylococcal agent. Microbes Infect. 2004, 6, 86-92. (Pubitemid 38114825)
36. Sato, M.; Tanaka, H.; Fujiwara, S.; Hirata, M.; Yamaguchi, R.; Etoh, H.; Tokuda, C. Antibacterial property of isoflavonoids isolated from Erythrina variegata against cariogenic oral bacteria. Phytomedicine 2003, 10, 427-433. (Pubitemid 36745167)
37. Weidenborner, M.; Hindorf, H.; Jha, H. C.; Tsotsonos, P.; Egge, H. Antifungal activity of isoflavonoids in different reduced stages on Rhizoctonia solani and Sclerotium rolfsii. Phytochemistry 1990, 29, 801-803.
38. Kramer, R. P.; Hindorf, H.; Jha, H. C.; Kallage, J.; Zilliken, F. Antifungal activity of soybean and chickpea isoflavonec and their reduced derivatives Phytochemistry 1984, 23, 2203-2205.
39. Rojas, R.; Bustamante, B.; Ventosilla, P.; Fernadez, I.; Caviedes, L.; Gilman, R. H.; Lock, O.; Hammond, G. B. Larvicidal, antimycobacterial and antifungal compounds from the bark of the Peruvian plant Swartzia polyphylla DC. Chem. Pharm. Bull. 2006, 54, 278-279. (Pubitemid 43200619)
40. Lechner, D.; Gibbons, S.; Bucar, F. Plant phenolic compounds as ethidium bromide efflux inhibitors in Mycobacterium smegmatis. J. Antimicrob. Chemother. 2008, 62, 345-348.
41. Sklenickova, O.; Flesar, J.; Kokoska, L. Selective antimicrobial activity of isoflavonoids. Ann. Nutr. Metab. 2009, 55, 391.
42. Paredes, C. J.; Alsaker, K. V.; Papoutsakis, E. T. A Comparative Genomic View of Clostridial Sporulation and Physiology. Nat. Rev. Microbiol. 2005, 3, 969-978.
43. Yuli, S.; Chengxu, L.; Sydney, F. M. Multiplex PCR for rapid differentiation of three species in the "Clostridium clostridioforme group". FEMS Microbiol. Lett. 2005, 244, 391-395. (Pubitemid 40342856)
44. Brook, I. Clostridial infection in children. J. Med. Microbiol. 1995, 42, 78-82.
45. Mattoo, J.; van Hoek, A.; Domig, K. J.; Saarela, M.; Florez, A. B.; Brockmann, E.; Amtmann, E.; Mayo, B.; Aarts, H. J. M.; Danielsen, M. Susceptibility of human and probiotic Bifidobacterium spp. to selected antibiotics as determined by the Etest method. Int. Dairy J. 2007, 17, 1123-1131. (Pubitemid 46891232)
46. Kiwaki, M.; Sato, T. Antimicrobial susceptibility of Bifidobacterium breve strains and genetic analysis of streptomycin resistance of probiotic B. breve strain Yakult. Int. J. Food Microbiol. 2009, 134, 211-215.
47. Morel, C.; Stermitz, F. R.; Tegos, G.; Lewis, K. Isoflavones as potentiators of antibacterial activity. Int. J. Food Microbiol. 2003, 51, 5677-5679.
48. Sato, M.; Tanaka, H.; Tani, N.; Nagayama, M.; Yamaguchi, R. Different antibacterial actions of isoflavones isolated from Erythrina poeppigiana against methicillin-resistant Staphylococcus aureus. Lett. Appl. Microbiol. 2006, 43, 243-248.
49. Saviranta, N. M.; Anttonen, M. J.; von Wright, A.; Karjalainen, R. O. Red clover (Trifolium pratense L.) isoflavones: determination of concentrations by plant stage, flower colour, plant part and cultivar, J. Sci. Food Agric. 2008, 88, 125-132.
50. Batterha, T. J.; Shutt, D. A.; Hart, N. K.; Braden, A. W. H.; Tweeddal, H. J. Metabolism of intraruminally administered [4-C-14]formononetin and [4-C-14]biochanin A in sheep. Aust. J. Agric. Res. 1971, 22, 131-138.
51. Davies, F. T.; Calderon, C. M.; Human, Z.; Gomez, R. Influence of a flavonoid (formononetin) on mycorrhizal activity and potato crop productivity in the highlands of Peru. Sci. Hortic.-Amsterdam 2005, 106, 318-329.
52. Occhiuto, F.; Zangla, G.; Samperi, S.; Palumbo, D. R.; Pino, A.; De Pasquale, R.; Circosta, C. The phytoestrogenic isoflavones from Trifolium pratense L. (Red clover) protects human cortical neurons from glutamate toxicity. Phytomedicine 2008, 15, 676-682.
53. Morimoto, K.; Karita, S.; Kimura, T.; Sakka, K.; Ohmiya, K. Characterization of Clostridium paraputrificum Chitanase A from a Recombinant Escherichia coli. J. Biosci. Bioeng. 2001, 92, 466-468.
54. Evvyernie, D.; Yamazaki, S.; Morimoto, K.; Karita, S.; Kimura, T.; Sakka, K.; Ohmiya, K. Identification and Characterization of Clostridium paraputrificum M-21, a Chitinolytic, Mesophilic and Hydrogen-Producing Bacterium. J. Biosci. Bioeng. 2000, 89, 596-601.
55. Cushnie, T. P. T.; Lamb, A. J. Antimicrobial activity of flavonoids. Int. J. Antimicrob. Agents 2005, 26, 343-356.
56. Tsuchiya, H.; Sato, M.; Miyazaki, T.; Fujiwara, S.; Tanigaki, S.; Ohyama, M.; Tanaka, T.; Iinuma, M. Comparative study on the antibacterial activity of phytochemical flavanones against methicillin-resistant Staphylococcus aureus. J. Ethnopharmacol. 1996, 50, 27-34. (Pubitemid 26028892)
57. Jorgensen, J. H.; Turnidge, J. D. Antimicrobial Susceptibility Testing: General Considerations. In Manual Of Clinical Microbiology, 7th ed.; Murray, P. R., Baron, E. J., Pfaller, M. A., Al., E., Eds.; ASM Press: Washington, DC, USA, 1999; pp. 1469-1473.